• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Recent Advances in the Study of 4-Bromo-5-chloro-N,2-dimethylbenzamide (CAS: 2734774-15-1)

4-Bromo-5-chloro-N,2-dimethylbenzamide (CAS: 2734774-15-1) is a chemical compound of significant interest in the field of medicinal chemistry and drug discovery. Recent studies have explored its potential as a key intermediate in the synthesis of novel therapeutic agents, particularly in the development of kinase inhibitors and other small-molecule drugs. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in pharmaceutical research.

A recent study published in the Journal of Medicinal Chemistry investigated the synthetic pathways for 4-Bromo-5-chloro-N,2-dimethylbenzamide, highlighting its role as a versatile building block in the construction of more complex molecules. The researchers employed a multi-step synthesis approach, starting from commercially available precursors, and achieved a high yield of the target compound. The study also emphasized the compound's stability under various reaction conditions, making it a reliable intermediate for further derivatization.

In another study, the biological activity of 4-Bromo-5-chloro-N,2-dimethylbenzamide was evaluated in the context of cancer research. The compound demonstrated moderate inhibitory activity against certain kinase targets, which are often implicated in tumor growth and proliferation. While the initial results are promising, further optimization of the compound's structure is required to enhance its potency and selectivity. Researchers are currently exploring modifications to the benzamide scaffold to improve its pharmacokinetic properties.

Additionally, computational modeling studies have provided insights into the binding interactions of 4-Bromo-5-chloro-N,2-dimethylbenzamide with its target proteins. Molecular docking simulations revealed that the compound occupies the ATP-binding site of specific kinases, suggesting a potential mechanism of action. These findings are being used to guide the design of next-generation inhibitors with improved efficacy and reduced off-target effects.

The pharmaceutical industry has also taken note of the potential applications of 4-Bromo-5-chloro-N,2-dimethylbenzamide. Several patent applications have been filed in recent years, covering its use in combination therapies and as a scaffold for drug discovery. Industry analysts predict that the demand for this compound will increase as more research validates its utility in developing targeted therapies for various diseases.

In conclusion, 4-Bromo-5-chloro-N,2-dimethylbenzamide (CAS: 2734774-15-1) represents a promising candidate for further investigation in medicinal chemistry. Its synthetic accessibility, biological activity, and potential for structural optimization make it a valuable tool for researchers. Future studies should focus on elucidating its mechanism of action in greater detail and exploring its applications in preclinical models. The ongoing research in this area underscores the compound's relevance in the rapidly evolving field of chemical biology and drug development.

• 862470-16-4(BENZAMIDE, 5-CHLORO-N,2-DIMETHYL-)
• 791137-22-9(3-Bromo-4-chlorobenzamide)
• 893420-18-3(4-Bromo-N,2-dimethylbenzamide)
• 446855-39-6(4-bromo-n-(4-chlorobenzyl)benzamide)
• 1228826-41-2(4-Bromo-3-chlorobenzamide)
• 1306629-10-6(N-(4-Bromobenzyl)-4-chlorobenzamide)
• 1304876-58-1(N-(4-Bromobenzyl)-3-chlorobenzamide)
• 640286-60-8(2-formyl-4-chloro-N-methylbenzamide)
• 515135-61-2(3-bromo-4-chloro-N-cyclopropylbenzamide)
• 6116-49-0(3-bromo-N-(4-chlorobenzyl)benzamide)